Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients-Reference-Cited by-同舟云学术

Antibody induction versus placebo, no induction, or another type of antibody induction for liver transplant recipients

Published:2014-06-05 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Penninga Luit¹²,Wettergren André³,Wilson Colin H⁴,Chan An-Wen⁵,Steinbrüchel Daniel A⁶,Gluud Christian⁷

Affiliation:

1. Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812; Blegdamsvej 9 Copenhagen Denmark DK-2100

2. Rigshospitalet, Copenhagen University Hospital; Department of Surgery and Transplantation C2122; Blegdamsvej 9 Copenhagen Denmark DK-2100 Ø

3. Surgical Clinic Hvidovre; Hvidovrevej 342, 1. floor Hvidovre Denmark 2650

4. The Freeman Hospital; Institute of Transplantation; Freeman Road High Heaton Newcastle upon Tyne Tyne and Wear UK NE7 7DN

5. University of Toronto; Women's College Research Institute; 790 Bay St, Rm 735 Toronto ON Canada

6. Rigshospitalet, Copenhagen University Hospital; Department of Cardiothoracic Surgery; Blegdamsvej 9 Copenhagen Denmark DK-2100

7. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; The Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100

Publisher

Wiley

Subject

Pharmacology (medical)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/14651858.CD010253.pub2/fullpdf

Reference117 articles.

1. Bogetti D Jarzembowski T-M Sankary H-N Manzelli A Knight P-S Chejfec G Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy Transplantation Proceedings 2005 404 6

2. Bogetti D Sankary HN Chejfec G Cotler S Testa G Benedetti E Thymoglobulin (TG) induction protects liver allografts from ischemia/reperfusion injury (IRI) American Journal of Transplantation 2004 25

3. Boillot O Poncet G Méchet I Dumortier J Delafosse B Sagnard P Randomized trial of triple based immunosuppression using tacrolimus, mycophenolate mofetil and steroids quadruple regimen induction with thymoglobulin in liver transplantation Hepatology 2000 599A

4. Thymoglobulin induction in liver transplant recipients with a tacrolimus, mycophenolate mofetil, and steroid immunosuppressive regimen: a five-year randomized prospective study;Boillot;Liver Transplantation,2009

5. Assessing renal function with daclizumab induction and delayed tacrolimus introduction in liver transplant recipients;Calmus;Transplantation,2010

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological immunosuppressive agents used in liver transplantation;Annals of Liver Transplantation;2023-11-24

2. T-cell specific antibody induction versus corticosteroid induction immunosuppression for liver transplant recipients: a meta-analysis;Scientific Reports;2023-04-28

3. Immunosuppression and Liver Transplantation;Engineering;2023-02

4. Comments on: Induction Immunosuppression Does Not Worsen Tumor Recurrence After Liver Transplantation for Hepatocellular Carcinoma;Transplantation;2023-01-25

5. Strategies for ABO Incompatible Liver Transplantation;Journal of Clinical and Experimental Hepatology;2022-12